PMID- 9605521 OWN - NLM STAT- MEDLINE DCOM- 19980727 LR - 20201209 IS - 0303-7207 (Print) IS - 0303-7207 (Linking) VI - 137 IP - 2 DP - 1998 Feb TI - Prolactin induces expression of FGF-2 and a novel FGF-responsive NonO/p54nrb-related mRNA in rat lymphoma cells. PG - 187-95 AB - The rat Nb2-11C lymphoma cell line expresses high affinity prolactin (PRL) receptors, and requires lactogenic hormones for survival and proliferation. We have applied differential display to identify genes which are differentially induced in Nb2-11C cells following PRL stimulation, or which are constitutively expressed in the PRL-independent Nb2-Sp cells. In the present study we characterized a clone (22c.2) which was expressed in Nb2-Sp cells, and in Nb2-11C cells given PRL for 3 h but not in untreated cells. The 279 bp cDNA had 95% homology with the 3' end of the murine 2.6 kb FGF-inducible gene 14 (FIN14). When clone 22c.2 was used to screen a Nb2-Sp cDNA library to obtain a longer cDNA, a unique 1039 bp clone PNR (Prolactin-responsive/ NonO-Related) was isolated, subcloned and sequenced. The deduced amino acid sequence encoded by the PNR open reading frame had significant homology with a family of RNA- and DNA-binding proteins which include the human polypyrimidine tract-binding protein (PTB)-associated splicing factor (PSF), the murine non-POU-domain-containing octamer-binding protein (NonO) and the human NonO homologue p54nrb. Nb2-11C cells expressed three PNR-related mRNA transcripts of 2.5, 3.0 and > 10 kb. Expression of the 2.5 and 3.0 kb transcripts were increased at least 4-fold within 3 h of PRL treatment. PNR expression was also significantly stimulated within 3 h by addition of FGF-2 to either Nb2-11C or Nb2-Sp cells, although alone FGF-2 was not mitogenic for either cell line. Reverse transcription-polymerase chain reaction (RT-PCR) confirmed the expression of both FGF-2 and FGF receptor mRNA in Nb2 cells. raising the possibility of an autocrine or paracrine function for FGF-2 in lymphoma cells. Furthermore, PRL rapidly stimulated the expression of FGF-2 mRNA in a time- and dose-dependent manner in both Nb2-11C and Nb2-Sp cells. FGF-2 expression was increased within 1 h and was maintained at a high level for at least 10 h following treatment with 2 ng/ml PRL. Western blotting with anti-FGF2 antisera demonstrated PRL stimulation of intracellular accumulation, but not secretion of immunoreactive FGF-2. The observation of PRL-responsive expression of FGF-2 in Nb2 cells suggests a previously unrecognized pathway for PRL action in lymphoid cells. FAU - Too, C K AU - Too CK AD - Department of Biochemistry, Dalhousie University, Halifax, Nova Scotia, Canada. CTOO@IS.DAL.CA FAU - Knee, R AU - Knee R FAU - Pinette, A L AU - Pinette AL FAU - Li, A W AU - Li AW FAU - Murphy, P R AU - Murphy PR LA - eng SI - GENBANK/AF036335 PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Mol Cell Endocrinol JT - Molecular and cellular endocrinology JID - 7500844 RN - 0 (DNA Primers) RN - 0 (DNA, Complementary) RN - 0 (DNA-Binding Proteins) RN - 0 (NONO protein, human) RN - 0 (Nuclear Matrix-Associated Proteins) RN - 0 (Nuclear Proteins) RN - 0 (Octamer Transcription Factors) RN - 0 (RNA, Messenger) RN - 0 (RNA, Neoplasm) RN - 0 (RNA-Binding Proteins) RN - 103107-01-3 (Fibroblast Growth Factor 2) RN - 9002-62-4 (Prolactin) SB - IM MH - Amino Acid Sequence MH - Animals MH - Base Sequence MH - DNA Primers/genetics MH - DNA, Complementary/genetics/isolation & purification MH - DNA-Binding Proteins MH - Fibroblast Growth Factor 2/biosynthesis/*genetics/pharmacology MH - Gene Expression/drug effects MH - Humans MH - Lymphocytes/drug effects/metabolism MH - Lymphoma/genetics/metabolism MH - Molecular Sequence Data MH - *Nuclear Matrix-Associated Proteins MH - Nuclear Proteins/*genetics MH - Octamer Transcription Factors MH - Polymerase Chain Reaction MH - Prolactin/*pharmacology MH - RNA, Messenger/genetics/metabolism MH - RNA, Neoplasm/genetics/metabolism MH - RNA-Binding Proteins/*genetics MH - Rats MH - Tumor Cells, Cultured EDAT- 1998/05/30 00:00 MHDA- 1998/05/30 00:01 CRDT- 1998/05/30 00:00 PHST- 1998/05/30 00:00 [pubmed] PHST- 1998/05/30 00:01 [medline] PHST- 1998/05/30 00:00 [entrez] AID - S0303-7207(97)00240-2 [pii] AID - 10.1016/s0303-7207(97)00240-2 [doi] PST - ppublish SO - Mol Cell Endocrinol. 1998 Feb;137(2):187-95. doi: 10.1016/s0303-7207(97)00240-2.